Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.000001 per share
-
Shares outstanding
-
139,295,316
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
74,502,096
-
Shares change
-
+741,731
-
Total reported value, excl. options
-
$175,824,000
-
Value change
-
+$1,768,228
-
Number of buys
-
11
-
Number of sells
-
-3
-
Price
-
$2.36
Significant Holders of Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) as of Q1 2021
16 filings reported holding XTNT - Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share as of Q1 2021.
Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74,502,096 shares
of 139,295,316 outstanding shares and own 53.48% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (72,873,494 shares), RENAISSANCE TECHNOLOGIES LLC (921,771 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (372,300 shares), CITADEL ADVISORS LLC (91,973 shares), Tower Research Capital LLC (TRC) (52,640 shares), MARSHALL WACE, LLP (47,559 shares), VANGUARD GROUP INC (44,170 shares), PRICE T ROWE ASSOCIATES INC /MD/ (27,900 shares), HRT FINANCIAL LP (21,326 shares), and GEODE CAPITAL MANAGEMENT, LLC (21,204 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.